SVG 30X
Alternative Names: SVG-30XLatest Information Update: 09 Sep 2024
At a glance
- Originator SoVarGen
- Class Antineoplastics; RNA
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Brain cancer
Most Recent Events
- 28 Aug 2024 Early research in Brain cancer in South Korea (Parenteral) prior to August 2024 (SoVarGen pipeline, August 2024)